4 things to know about disease-modifying treatment for adults with spinal muscular atrophy
Real-world evidence shows preserved motor function and quality of life benefits
This content has been independently produced by ADG, made possible through sponsorship from Biogen.
Disease-modifying treatment for spinal muscular atrophy (SMA) has been available in Australia since 2017, with a growing body of real-world evidence supporting the treatment of adults with SMA to preserve motor function and prevent further decline.
